drugset / Trial / NCT05445895

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

NCT05445895

Phase 4 Completed 483 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to Evaluate the Efficacy and Safety of Renexin CR in patients with Acute Non-cardioembolic Ischemic Stroke

Timeline

Start
2022-12-16
Primary completion
2025-10-02
Completion
2025-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 200 mg
Comparator Clopidogrel Small molecule 75 mg
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 160 mg

Indications